Jocelyn Kaiser. Show Affiliations »
Abstract
Mesh: See more » Antiviral Agents/economicsCOVID-19COVID-19 VaccinesClinical Trials as TopicCoronavirus Infections/drug therapyCoronavirus Infections/economicsCoronavirus Infections/prevention & controlHumansNational Institutes of Health (U.S.)Pandemics/prevention & controlPneumonia, Viral/drug therapyPneumonia, Viral/prevention & controlUnited StatesViral Vaccines/economics
Substances: See more » Antiviral AgentsCOVID-19 VaccinesViral Vaccines
Year: 2020 PMID: 32327575 DOI: 10.1126/science.368.6489.351
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728